11 The Nottingham biochemical index (ESR, CEA, CA 15.3): a marker of therapeutic response in metastatic breast cancer and its potential role in rationalising breast cancer therapy

The Breast ◽  
1995 ◽  
Vol 4 (1) ◽  
pp. 67
Author(s):  
A.R. Dixon
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Therapy ◽  
Potential Role ◽  
Therapeutic Response ◽  
Metastatic Breast ◽  
Breast Cancer Therapy ◽  
Ca 15.3 ◽  
Biochemical Index

ESR, CEA, CA 15.3 & EMCA have a role in directing metastatic breast cancer therapy

The Breast ◽  
1992 ◽  
Vol 1 (3) ◽  
pp. 165
Author(s):  
AR Dixon ◽  
S Chan ◽  
RA Badley ◽  
MR Price ◽  
P Sibling ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Therapy ◽  
Metastatic Breast ◽  
Breast Cancer Therapy ◽  
Ca 15.3

Co-administration of biocompatible self-assembled polylactic acid–hyaluronic acid block copolymer nanoparticles with tumor-penetrating peptide-iRGD for metastatic breast cancer therapy

2018 ◽  
Vol 6 (19) ◽  
pp. 3163-3180 ◽  
Author(s):  
Caifeng Deng ◽  
Xiaohong Xu ◽  
Drunp Tashi ◽  
Yongmei Wu ◽  
Bingyin Su ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Hyaluronic Acid ◽  
Metastatic Breast Cancer ◽  
Block Copolymer ◽  
Cancer Therapy ◽  
Polylactic Acid ◽  
Targeted Delivery ◽  
Metastatic Breast ◽  
Chemotherapeutic Drugs ◽  
Breast Cancer Therapy

The safe and efficient targeted delivery of chemotherapeutic drugs has remained a challenge in metastatic breast cancer therapy.

scholarly journals Co-delivery of dihydroartemisinin and docetaxel in pH-sensitive nanoparticles for treating metastatic breast cancerviathe NF-κB/MMP-2 signal pathway

RSC Advances ◽  
2018 ◽  
Vol 8 (39) ◽  
pp. 21735-21744 ◽  
Author(s):  
Jin Tao ◽  
Zeng Tan ◽  
Lu Diao ◽  
Zhonghua Ji ◽  
Jiahuan Zhu ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Therapy ◽  
Synergistic Effects ◽  
Metastatic Breast ◽  
Signal Pathway ◽  
Ph Sensitive ◽  
Breast Cancer Therapy

Co-delivery DTX and DHA as acid-sensitive nanoparticles to exert synergistic effects for metastatic breast cancer therapy.

CXCR4-Targeted and Redox Responsive Dextrin Nanogel for Metastatic Breast Cancer Therapy

2017 ◽  
Vol 18 (6) ◽  
pp. 1793-1802 ◽  
Author(s):  
Feiran Zhang ◽  
Siman Gong ◽  
Jun Wu ◽  
Huipeng Li ◽  
David Oupicky ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Therapy ◽  
Metastatic Breast ◽  
Breast Cancer Therapy ◽  
Redox Responsive

scholarly journals Genomic mutation-driven metastatic breast cancer therapy: a single center experience

Oncotarget ◽  
2017 ◽  
Vol 8 (16) ◽  
pp. 26414-26423 ◽  
Author(s):  
Yuan Yuan ◽  
Susan E. Yost ◽  
John Yim ◽  
Yate-Ching Yuan ◽  
Nicola M. Solomon ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Therapy ◽  
Metastatic Breast ◽  
Single Center ◽  
Breast Cancer Therapy ◽  
Single Center Experience ◽  
Genomic Mutation

scholarly journals Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experience

Oncotarget ◽  
2017 ◽  
Vol 8 (37) ◽  
pp. 62817-62817 ◽  
Author(s):  
Yuan Yuan ◽  
Susan E. Yost ◽  
John Yim ◽  
Yate-Ching Yuan ◽  
Nicola M. Solomon ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Cancer Therapy ◽  
Metastatic Breast ◽  
Single Center ◽  
Breast Cancer Therapy ◽  
Single Center Experience ◽  
Genomic Mutation
Sign in / Sign up

Export Citation Format

Share Document